EMJ Podcast: Insights For Healthcare Professionals

In this episode, our experts discuss the recommended clinical anti-TNF treatments for inflammatory bowel disease in Europe and the USA and the patient factors that should be considered in patient decision-making.

This podcast series has been supported by Viatris, who were not involved in the creation of this content.

In this episode, our expert gastroenterologists provide a summary of the current ECCO and AGA recommendations for the use of anti-TNFs and insights on potential updates.

This podcast series has been supported by Viatris, who were not involved in the creation of this content.

This introductory episode provides an introduction to the role anti-TNF therapies play in the management of inflammatory bowel disease, ulcerative colitis and Crohn’s disease

This podcast series has been supported by Viatris, who were not involved in the creation of this content.

In this week’s episode, Jonathan and George Bakris, Comprehensive Hypertension Center, University of Chicago, Illinois, USA, chat about hypertension and renal denervation.

Use the following timestamps to navigate the content in this episode:

(00:00)-Introduction

(00:40)-Renal denervation Vs drugs in development for resistant hypertension

(06:06)-Get with the guidelines

(11:05)-Disparities in kidney disease incidence

(16:25)-Novel diabetes drugs

(19:42)-Remaining challenges in treating hypertension

(26:30)-Three wishes for healthcare

This podcast is supported by Medtronic.

This podcast episode, moderated by George Cooper, provides an exploration of the latest European Society of Hypertension (ESH) guidance on the use of renal denervation in uncontrolled hypertension management.

Atul Pathak, Princess Grace Hospital, Monaco, joins EMJ to offer key insights on renal denervation.

In this week’s episode, Jonathan and George Bakris, Comprehensive Hypertension Center, University of Chicago, Illinois, USA, discuss the role of music in medical practice, before diving into hypertension and ambulatory blood pressure monitoring. 

Use the following timestamps to navigate the content in this episode:

(00:00)-Introduction

(02:47)-Hoosiers and music

(08:45)-Routes into medicine

(09:47)-Finding hypertension

(13:50)-Ambulatory blood pressure monitoring

(15:10)-White coat hypertension

(16:30)-Lowering your blood pressure

(18:09)-An innocent murmur

(18:59)-Markers of kidney and heart disease

(21:10)-Two most common causes of kidney disease

(23:18)-Arterial stiffness

In this episode, Jonathan chats with Mark Little, Consultant Interventional Radiologist at the Royal Berkshire NHS Foundation Trust, Reading, UK, where he has set up a large embolotherapy research group in addition to his clinical work. The two discuss everything from their shared passion for aviation to developments in prostate artery embolisation.

Use these timestamps to navigate our episode!

(00:00)-Introduction

(02:32)-What led Little to pursue a career in radiology

(09:01)-Prostate artery embolisation

(15:02)-Genicular artery embolisation

(21:40)-Uterine artery embolisation

(24:43)-The TARGET trial: using augmented reality to guide prostate cancer biopsy

(28:05)-The role of AI in radiology

(31:50)-Innovations on the horizon for interventional radiology

(35:23)-Three wishes

In this week’s episode, Jonathan is joined by Stephanie Hanna, a Research Fellow for the Diabetes Research and Wellness Foundation, in the Division of Infection and Immunity, at Cardiff University’s School of Medicine, Wales, UK. In this fascinating episode, the pair discuss all things diabetes, including immunotherapy, the future of diagnosis, and how to predict your diabetes risk.

Use the following timestamps to navigate the content in this episode: 

(00:00)-Introduction

(01:22)-Getting into Type 1 diabetes (T1D)

(02:23)-Stages of T1D

(05:04)-Biomarkers of T1D

(07:01)-Phenotypic analysis of T and B-cells

(08:24)-Diabetes progression

(10:11)-Immunotherapy for T1D

(14:00)-Challenges in measuring immune response

(16:22)-Some thoughts on artificial intelligence

(18:11)-How to get involved in a study

(19:27)-Checking your own antibody status

(23:51)-Thyroid eye disease

(25:19)-Risks of overlooking T1D

(27:34)-Three wishes for the future of healthcare

Dr Teresa Amaral and Prof Mario Mandalà discuss: The typical patient for whom adjuvant therapy may be considered, and provide details on therapy choices. The long-term advantages of adjuvant treatments, and prospects for the use of biomarkers to help elucidate the best candidates for such therapies. The potential disadvantages of adjuvant therapy, and how more studies are needed to understand if these therapies can impact quality of life and fertility.

This content was fully funded by Novartis Pharma AG

In this bonus episode of the EMJ Podcast, host Brigitte Scott is joined by Ketta Lorusso, Humanitas University, Milan, Italy; and Rob Coleman, Vaniam Group, Chicago, Illinois, USA, who discuss key developments in endometrial cancer research that were presented in 2023.

This podcast was funded by a medical educational grant from GSK, with the purpose of enhancing the fundamental understanding of oncology specialists of key data and the latest advancements in endometrial cancer care. This content is not intended for US Healthcare Professionals.